Health Evolution conducted original research to determine CEO priorities over the next two years and 61 percent responded that technology is atop that list — with deploying innovations ranked second. The five investment priorities: telemedicine, consumer engagement, population health, mobile apps and AI. While our research concluded in February of 2020, early evidence suggests that COVID-19 has already accelerated investments in those and other technologies.
To that end, we created the Health Evolution Innovation Lab to help connect innovators and provider, payer and life sciences CEOs.
“Too often, health care innovation is asymmetric. Many are solutions looking for problems and too many problems don’t have solutions. The Innovation Lab is a way of bringing the CEO’s perspective to innovation: solve problems for my organization fast and at scale” said Health Evolution Chairman David Brailer, MD. “The Innovation Lab is critical to our mission to inspire courageous leadership in health care. CEOs of health care companies want to try new innovations but need to know how well they performed in their peers’ organizations. The Innovation Lab allows peer-to-peer sharing of ideas.”
The Health Evolution Innovation Lab consists of three foundational content offerings. Impact Report case studies highlight one customer’s successful implementation of a technology to address specific problems or create new opportunities, Innovation Guides dive deep into the problem to illustrate the innovator’s domain expertise relative to the broader trend and innovator CEO profiles complete the picture by telling a company’s story.
“CEOs leading organizations of all sizes can learn a considerable amount from those on the forefront of clinical and financial success and that is as true among physician and provider networks as it is within any other sector,” said Bob Segert, CEO, athenahealth, a participant in early testing of the Health Evolution Innovation Lab. “Connecting innovative companies with health care CEOs will help the broader ecosystem leverage technologies to improve clinical and financial performance.”
The need to evaluate and rapidly deploy technologies is more pervasive and pressing during this pandemic than it has ever been — as is the ability to understand tangible benefits of various products.
Innovation Lab reports are specifically designed for busy chief executives with CEO takeaways, concise explanations of the problem and tangible business results.
“With COVID-19 exposing many consumers and caregivers to telehealth for the first time, it’s more important than ever for health plans and health systems to have a place to come together to share best practices and lessons-learned related to shifting care into the home,” said Roy Schoenberg, MD, CEO of Amwell, which is also an initial Innovation Lab participant. “With the right technology and playbook, we can overcome access challenges associated with geographic and socioeconomic conditions, and completely reimagine our ability to serve some of the most vulnerable – the elderly and those suffering from chronic conditions and rare disease.”
Moving into the future, CEOs will also need to understand how connected technologies can be harnessed for accurate diagnoses, personalized treatments, streamlined operations and greater efficiencies on the clinical, financial and operational business functions across the health care enterprise.
“On the path forward, digital technology can no longer exist in a silo. Business leaders are recognizing this, digital innovation steering committees have proliferated, reflecting the desire for digital transformation at the C-suite and board levels,” said Bernd Montag, CEO, Siemens Healthineers, which is also participating in the Innovation Lab. “Digital innovation isn’t a goal or an initiative — it’s the very water we swim in. Breaking down the silos is the key to digitalizing healthcare.”
